Nephrotic syndrome associated with gastric cancer.
A patient whose nephrotic syndrome was controlled by steroids and cyclophosphamide was found to have gastric cancer. After removal of the tumor and discontinuing the steroid therapy, no recurrence of the clinical signs of nephrotic syndrome appeared, but moderate proteinuria persisted. The literature regarding the association of nephrotic syndrome with malignancies is reviewed.
D000230:Adenocarcinoma / Q000150:complications* / Q000601:surgery; D003520:Cyclophosphamide / Q000627:therapeutic use; D006801:Humans; D008297:Male; D008875:Middle Aged; D009404:Nephrotic Syndrome / Q000188:drug therapy / Q000209:etiology* / Q000473:pathology; D011241:Prednisone / Q000627:therapeutic use; D013274:Stomach Neoplasms / Q000150:complications* / Q000601:surgery
D003520:Cyclophosphamide; D011241:Prednisone